Dan‐yun Lai
YOU?
Author Swipe
View article: Incidence and management of appendicitis at 6 years in Shicheng County of China
Incidence and management of appendicitis at 6 years in Shicheng County of China Open
View article: Research on the Criminal Liability for Traffic Accidents of Autonomous Vehicles
Research on the Criminal Liability for Traffic Accidents of Autonomous Vehicles Open
In recent years, China’s automobile industry has improved rapidly, in the premise of making great progress in the field of traditional fuel vehicles. With the development of artificial intelligence technologies such as cloud computing and …
View article: Age- and Severity-Associated Humoral Immunity Response in COVID-19 Patients: A Cohort Study from Wuhan, China
Age- and Severity-Associated Humoral Immunity Response in COVID-19 Patients: A Cohort Study from Wuhan, China Open
Age has been found to be the single most significant factor in COVID-19 severity and outcome. However, the age-related severity factors of COVID-19 have not been definitively established. In this study, we detected SARS-CoV-2-specific anti…
View article: Longitudinal neutralization activities on authentic Omicron variant provided by three doses of BBIBP‐CorV vaccination during one year
Longitudinal neutralization activities on authentic Omicron variant provided by three doses of BBIBP‐CorV vaccination during one year Open
The majority of people in China have been immunized with the inactivated viral vaccine BBIBP‐CorV. The emergence of the Omicron variant raised the concerns about protection efficacy of the inactivated viral vaccine in China. However, longi…
View article: Ultrasensitive monitoring of SARS-CoV-2-specific antibody responses based on a digital approach reveals one week of IgG seroconversion
Ultrasensitive monitoring of SARS-CoV-2-specific antibody responses based on a digital approach reveals one week of IgG seroconversion Open
View article: Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19
Evaluation of Spike Protein Epitopes by Assessing the Dynamics of Humoral Immune Responses in Moderate COVID-19 Open
The coronavirus disease 2019 (COVID-19) pandemic is caused by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The spike protein (S) of SARS-CoV-2 is a major target for diagnosis and vaccine developm…
View article: SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling
SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling Open
View article: SARS-CoV-2-specific antibody response characteristics in COVID-19 patients of different ages
SARS-CoV-2-specific antibody response characteristics in COVID-19 patients of different ages Open
Age has been found to be one of the main risk factors for the severity and outcome of COVID-19. However, differences in SARS-CoV-2 specific antibody responses among COVID-19 patients of different age groups remain largely unknown. In this …
View article: Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant
Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant Open
View article: One year landscape of the inactivated virus vaccine triggered RBD-specific IgG, IgM and IgA responses against the Omicron variant
One year landscape of the inactivated virus vaccine triggered RBD-specific IgG, IgM and IgA responses against the Omicron variant Open
We reported the first map of vaccine stimulated RBD-specific antibody responses (IgG, IgM and IgA) against the Omicron variant. We generated the map using a protein microarray, by analyzing longitudinal sera collected spanning one year fro…
View article: Longitudinal Neutralization Activities on Authentic Omicron Variant Provided by 3 Doses of BBIBP-CorV Vaccination During One Year
Longitudinal Neutralization Activities on Authentic Omicron Variant Provided by 3 Doses of BBIBP-CorV Vaccination During One Year Open
View article: Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients
Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients Open
View article: COVID-ONE-hi: The One-Stop Database for COVID-19-Specific Humoral Immunity and Clinical Parameters
COVID-ONE-hi: The One-Stop Database for COVID-19-Specific Humoral Immunity and Clinical Parameters Open
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, di…
View article: Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy
Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy Open
One of the best ways to control COVID-19 is vaccination. Among the various SARS-CoV-2 vaccines, inactivated virus vaccines have been widely applied in China and many other countries. To understand the underlying protective mechanism of the…
View article: COVID-ONE-humoral immune: The One-stop Database for COVID-19-specific Antibody Responses and Clinical Parameters
COVID-ONE-humoral immune: The One-stop Database for COVID-19-specific Antibody Responses and Clinical Parameters Open
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, di…
View article: COVID-ONE-humoral immune: The One-stop Database for COVID-19-specific Antibody Responses and Clinical Parameters
COVID-ONE-humoral immune: The One-stop Database for COVID-19-specific Antibody Responses and Clinical Parameters Open
Coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2, varies with regard to symptoms and mortality rates among populations. Humoral immunity plays critical roles in SARS-CoV-2 infection and recovery from COVID-19. However, di…
View article: SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling
SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling Open
View article: Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins
Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins Open
View article: Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution
Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution Open
View article: Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients Open
View article: Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients
Systematic evaluation of IgG responses to SARS-CoV-2 spike protein-derived peptides for monitoring COVID-19 patients Open
View article: Antibody Landscape Against SARS-CoV-2 Proteome Revealed Significant Differences between Non-Structural/ Accessory Proteins and Structural Proteins
Antibody Landscape Against SARS-CoV-2 Proteome Revealed Significant Differences between Non-Structural/ Accessory Proteins and Structural Proteins Open
View article: SARS-CoV-2 Antibody Signatures for Predicting the Outcome of COVID-19
SARS-CoV-2 Antibody Signatures for Predicting the Outcome of COVID-19 Open
View article: Antibody landscape against SARS-CoV-2 proteome revealed significant differences between non-structural/ accessory proteins and structural proteins
Antibody landscape against SARS-CoV-2 proteome revealed significant differences between non-structural/ accessory proteins and structural proteins Open
Summary The immunogenicity of SARS-CoV-2 proteome is largely unknown, especially for non-structural proteins and accessory proteins. Here we collected 2,360 COVID-19 sera and 601 control sera. We analyzed these sera on a protein microarray…
View article: Assessment and comparison of recombinant proteins from different sources for the detection of SARS-CoV-2 infection by using protein microarray
Assessment and comparison of recombinant proteins from different sources for the detection of SARS-CoV-2 infection by using protein microarray Open
View article: Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infections Open
Background The missing asymptomatic COVID‐19 infections have been overlooked because of the imperfect sensitivity of the nucleic acid testing (NAT). Globally understanding the humoral immunity in asymptomatic carriers will provide scientif…
View article: Systematic profiling of SARS-CoV-2 specific IgG epitopes at single amino acid resolution
Systematic profiling of SARS-CoV-2 specific IgG epitopes at single amino acid resolution Open
SARS-CoV-2 specific IgG responses play critical roles for patients to recover from COVID-19, in-depth dissecting of the IgG responses on systems level is of great interest. Herein, we adopted a newly developed high-throughput epitope mappi…
View article: Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients
Linear epitopes of SARS-CoV-2 spike protein elicit neutralizing antibodies in COVID-19 patients Open
ARS-CoV-2 outbreak is a world-wide pandemic. The Spike protein plays central role in cell entry of the virus, and triggers significant immuno-response. Our understanding of the immune-response against S protein is still very limited. Herei…
View article: Systematic evaluation of SARS-CoV-2 spike protein derived peptides for diagnosis of COVID-19 patients
Systematic evaluation of SARS-CoV-2 spike protein derived peptides for diagnosis of COVID-19 patients Open
Serological test plays an essential role in monitoring and combating COVID-19 pandemic. Recombinant spike protein (S protein), especially S1 protein is one of the major reagents for serological tests. However, the high cost in production o…
View article: Linear epitope landscape of SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
Linear epitope landscape of SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients Open
Neutralization antibodies and vaccines for treating COVID-19 are desperately needed. For precise development of antibodies and vaccines, the key is to understand which part of SARS-CoV-2 Spike protein is highly immunogenic on a systematic …